Raf, MEK, PI3K/mTOR and Pak inhibitors were active versus NF1-mutant MPNST cells, while EGFR, GSK3, and AKT inhibitors had almost no activity. The gene discussed is MAP2K7; the disease is malignant peripheral nerve sheath tumor.